fbpx

Companion Diagnostics tests helps your doctor determine if you are eligible for PARP inhibitors

Optimise your ovarian cancer treatment 

Myriad Genetics

Test performed by world renowned lab Myriad Genetics (USA). Positive Bioscience is the exclusive partner of Myriad in India.

US FDA Approved

First and ONLY US FDA approved comprehensive companion diagnostics test

Germline and Somatic Variants

Identifies both germline and somatic BRCA variants in the tumor.

GIS (HRD) Score

Only test available in India that calculates genomic instability

myChoiceCDx kit

Why myChoice Cdx?

Myriad Genetics is a leading molecular diagnostic company based in USA. Available in India, learn if you can take PARP inhibitors to treat your Ovarian Cancer with companion diagnostic test myChoice CDx.

Positive Bioscience is the exclusive partner for Myriad Genetics and only authorised provider of myChoice Cdx in India.

Our brochure explains in detail the benefits of the test as well as what is included. 

A test to help get the right treatment, to the right patient with ovarian cancer, at the right time.

myChoice CDx

Biomarkers for Homologous Recombination Deficiency (HRD)

myChoice HRD India Olaparib

Buy myChoice CDx

A test to help get the right treatment, to the right patient with ovarian cancer, at the right time.

Olaparib companion diagnostic

Order MyRisk Now

With over 20 years of experience, Myriad Genetics is a pioneer of cancer risk assessment. Get tested with Myriad and receive lifelong followup about your risks with MyRisk. 

Call Now ButtonCall Now